For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.

Eli Lilly's tirzepatide cut the risk of developing type 2 diabetes for people with pre-diabetes by 94%, according to new ...

Popular semaglutide-based drugs used for weight loss may reduce chronic and acute pain, which could make them a promising ...

Vitamin B12 is an essential nutrient found in a wide variety of foods. Learn more about the best food sources of vitamin B12 ...

More than 48 million Americans 12 years or older had a substance use disorder in 2022, yet only 24 percent received treatment ...

Are you ready to lose weight fast? Work with a weight loss clinic in Houston and embark on your weight loss journey with the ...

Struggling with weight loss? Layton Weight Loss Clinic has the solution! With Semaglutide and Tirzepitide treatments ...

Topline results were announced from a phase 3 clinical trial evaluating subcutaneous semaglutide in obesity and knee osteoarthritis.

In today's saturated market, finding weight loss supplements that genuinely deliver results without unwanted side effects feels like searching for a needle in a haystack. But 2024 is reshaping the ...

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% compared to similar medications, a new study found. But experts say more ...

Novo Nordisk has asked the Food and Drug Administration to bar compounding pharmacies from making copies of its blockbuster weight loss drug semaglutide, arguing that the medication is too complex ...

Just over a year ago, New Zealand customs officials started to intercept batches of injectable medications labelled Fitaro ...